The purpose of this study is to demonstrate that the Intraocular Pressure (IOP) lowering efficacy of Travoprost Ophthalmic Solution 0.004% is superior to that of Pilocarpine 1% in patients with chronic angle-closure glaucoma (CACG).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
30
One drop in each eye, once daily at 9 AM
One drop in each eye, forth times daily at 7 AM, 11 AM , 4 PM and 9 PM for twelve (12) weeks
Mean Intraocular Pressure (IOP)
Time frame: 4PM at Week 12 Visit
Number of Patients With Peripheral Anterior Synechiae (PAS)
Time frame: Week 12 Visit
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.